+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells



The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells



Cell Journal 13(3): 173-178



Despite of many benefits, umbilical cord blood (UCB) hematopoietic stem cell (HSC) transplantation is associated with low number of stem cells and slow engraftment; in particular of platelets. So, expanded HSCs and co-transfusion of megakaryocyte (MK) progenitor cells can shorten this period. In this study, we evaluated the cytokine conditions for maximum expansion and MK differentiation of CD133(+) HSCs. In this experimental study, The CD133(+) cells were separated from three cord blood samples by magnetic activated cell sorting (MACS) method, expanded in different cytokine combinations for a week and differentiated in thrombopoietin (TPO) for the second week. Differentiation was followed by the flow cytometry detection of CD41 and CD61 surface markers. Colony forming unit (CFU) assay and DNA analysis were done for colonogenic capacity and ploidy assay. CD133(+) cells showed maximum expansion in the stem span medium with stem cell factor (SCF) + FMS-like tyrosine kinase 3-ligand (Flt3-L) + TPO but the maximum differentiation was seen when CD133(+) cells were expanded in stem span medium with SCF + Interleukin 3 (IL-3) + TPO for the first and in TPO for the second week. Colony Forming Unit-MK (CFU-MK) was formed in three sizes of colonies in the mega-cult medium. In the DNA analysis; 25.2 ± 6.7% of the cells had more than 2n DNA mass. Distinct differences in the MK progenitor cell count were observed when the cells were cultured in stem span medium with TPO, SCF, IL-3 and then the TPO in the second week. Such strategy could be applied for optimization of CD133(+) cells expansion followed by MK differentiation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056189506

Download citation: RISBibTeXText

PMID: 23508472


Related references

Effects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133(+) cells into megakaryocyte progenitor cells. Cytokine 55(2): 181-187, 2011

Ex vivo expansion of megakaryocytic colony-forming cells from human umbilical cord blood. Blood 90(10 Suppl. 1 Part 1): 538A, 1997

Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells. Growth Factors 28(6): 409-416, 2010

Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(3): 645-649, 2008

Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(1): 146-150, 2010

Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 85-92, 2004

PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34 + cells. Experimental and Therapeutic Medicine 15(3): 2563-2568, 2018

Study on culture, identification and differentiation of CD133+ endothelial progenitor cells from human umbilical cord blood. Zhonghua Wai Ke Za Zhi 45(9): 619-622, 2007

Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. British Journal of Haematology 113(2): 470-478, 2001

In Vitro Differentiation of Human Umbilical Cord Blood CD133(+)Cells into Insulin Producing Cells in Co-Culture with Rat Pancreatic Mesenchymal Stem Cells. Cell Journal 17(2): 211-220, 2015

Megakaryocytic differentiation and apoptosis induced by thrombopoietin during ex vivo expansion of human cord blood CD34+ cells. Blood 94(10 Suppl. 1 Part 2): 154b, 1999

Comparison of ex vivo expansion of megakaryocytic cells from CD34-selected bone marrow, umbilical cord blood and mobilized peripheral blood progenitor cells. Blood 94(10 Suppl. 1 Part 2): 347b, 1999

Expansion of CD133(+) Umbilical Cord Blood Derived Hematopoietic Stem Cells on a Biocompatible Microwells. InternationalJournalofHematology-OncologyandStemCellResearch7(1):9, 2013

Efficient Expansion of SALL4-Transduced Umbilical Cord Blood Derived CD133+Hematopoietic Stem Cells. Acta Medica Iranica 55(5): 290-296, 2017

Study of in vitro expansion and differentiation into neuron-like cells of human umbilical cord blood mesenchymal stem cells. Zhonghua Xue Ye Xue Za Zhi 23(8): 415-419, 2002